Compare ALEMBIC with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs ELDER PHARMA - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC ELDER PHARMA ALEMBIC/
ELDER PHARMA
 
P/E (TTM) x 57.8 -0.2 - View Chart
P/BV x 5.0 0.1 4,940.0% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 ALEMBIC   ELDER PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-18
ELDER PHARMA
Jun-14
ALEMBIC/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs72380 18.9%   
Low Rs34188 18.0%   
Sales per share (Unadj.) Rs4.7491.2 1.0%  
Earnings per share (Unadj.) Rs6.1-3.2 -191.8%  
Cash flow per share (Unadj.) Rs6.214.4 43.3%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.7376.5 10.8%  
Shares outstanding (eoy) m267.0320.54 1,300.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.30.6 1,948.3%   
Avg P/E ratio x8.7-89.3 -9.7%  
P/CF ratio (eoy) x8.519.7 43.0%  
Price / Book Value ratio x1.30.8 172.6%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1395,833 242.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2072,179 9.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,25510,089 12.4%  
Other income Rs m370257 144.3%   
Total revenues Rs m1,62510,346 15.7%   
Gross profit Rs m111-792 -14.0%  
Depreciation Rs m38361 10.5%   
Interest Rs m22,756 0.1%   
Profit before tax Rs m442-3,653 -12.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m24125 19.1%   
Profit after tax Rs m1,630-65 -2,494.0%  
Gross profit margin %8.9-7.8 -112.8%  
Effective tax rate %5.4-3.4 -158.2%   
Net profit margin %129.8-0.6 -20,046.6%  
BALANCE SHEET DATA
Current assets Rs m1,8679,240 20.2%   
Current liabilities Rs m5919,998 5.9%   
Net working cap to sales %101.6-7.5 -1,353.5%  
Current ratio x3.20.9 341.7%  
Inventory Days Days9446 203.5%  
Debtors Days Days7460 122.7%  
Net fixed assets Rs m1,79110,124 17.7%   
Share capital Rs m534206 259.6%   
"Free" reserves Rs m10,3245,582 184.9%   
Net worth Rs m10,8587,734 140.4%   
Long term debt Rs m414,889 0.8%   
Total assets Rs m11,59122,882 50.7%  
Interest coverage x260.9-0.3 -80,199.6%   
Debt to equity ratio x00.6 0.6%  
Sales to assets ratio x0.10.4 24.6%   
Return on assets %14.111.8 119.7%  
Return on equity %15.0-0.8 -1,776.4%  
Return on capital %15.222.3 68.1%  
Exports to sales %1.53.0 50.9%   
Imports to sales %21.00.4 4,911.1%   
Exports (fob) Rs m19307 6.3%   
Imports (cif) Rs m26343 611.0%   
Fx inflow Rs m19307 6.3%   
Fx outflow Rs m264125 210.6%   
Net fx Rs m-244181 -134.8%   
CASH FLOW
From Operations Rs m23611,754 2.0%  
From Investments Rs m-224-561 40.0%  
From Financial Activity Rs m-27-6,762 0.4%  
Net Cashflow Rs m-154,432 -0.3%  

Share Holding

Indian Promoters % 64.0 39.6 161.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 7.5 2.7%  
FIIs % 9.7 16.8 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 36.1 72.3%  
Shareholders   54,701 16,479 331.9%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  WOCKHARDT  GSK PHARMA  PANACEA BIOTECH  

Compare ALEMBIC With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 22, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE ALEMBIC WITH

MARKET STATS